139 related articles for article (PubMed ID: 11698570)
1. Oxidative stress and p53 mutations in the carcinogenesis of iron overload-associated hepatocellular carcinoma.
Marrogi AJ; Khan MA; van Gijssel HE; Welsh JA; Rahim H; Demetris AJ; Kowdley KV; Hussain SP; Nair J; Bartsch H; Okby N; Poirier MC; Ishak KG; Harris CC
J Natl Cancer Inst; 2001 Nov; 93(21):1652-5. PubMed ID: 11698570
[No Abstract] [Full Text] [Related]
2. Dietary iron overload in the African and hepatocellular carcinoma.
Kew MC; Asare GA
Liver Int; 2007 Aug; 27(6):735-41. PubMed ID: 17617115
[TBL] [Abstract][Full Text] [Related]
3. Tumour promotion versus tumour suppression in chronic hepatic iron overload.
Bloomer SA; Brown KE
Cell Biochem Funct; 2015 Jun; 33(4):241-8. PubMed ID: 26059599
[TBL] [Abstract][Full Text] [Related]
4. [Iron overload and cancer].
Blanc JF; Bioulac-Sage P; Balabaud C
Bull Acad Natl Med; 2000; 184(2):355-63. PubMed ID: 10989544
[TBL] [Abstract][Full Text] [Related]
5. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
6. Iron and hepatocellular carcinoma.
Deugnier Y; Turlin B
J Gastroenterol Hepatol; 2001 May; 16(5):491-4. PubMed ID: 11350542
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
8. Aflatoxin and hepatocellular carcinoma: a useful paradigm for environmentally induced carcinogenesis.
Kolars JC
Hepatology; 1992 Sep; 16(3):848-51. PubMed ID: 1324219
[No Abstract] [Full Text] [Related]
9. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
Sikorska K; Bernat A; Wroblewska A
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil.
Torres DM; Harrison SA
Semin Liver Dis; 2012 Feb; 32(1):30-8. PubMed ID: 22418886
[TBL] [Abstract][Full Text] [Related]
11. Iron, friend or foe? "Freedom" makes the difference.
Pietrangelo A
J Hepatol; 2000 May; 32(5):862-4. PubMed ID: 10845676
[No Abstract] [Full Text] [Related]
12. A liver mass in an iron-overloaded thalassaemia intermedia patient.
Maakaron JE; Musallam KM; Ayache JB; Jabbour M; Tawil AN; Taher AT
Br J Haematol; 2013 Apr; 161(1):1. PubMed ID: 23294457
[No Abstract] [Full Text] [Related]
13. Disease progression and liver cancer in the ferroportin disease.
Corradini E; Ferrara F; Pollicino T; Vegetti A; Abbati GL; Losi L; Raimondo G; Pietrangelo A
Gut; 2007 Jul; 56(7):1030-2. PubMed ID: 17566043
[No Abstract] [Full Text] [Related]
14. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
15. P53 codon 249 mutation in hepatocellular carcinomas from Nigeria.
Ndububa DA; Yakicier CM; Ojo OS; Adeodu OO; Rotimi O; Ogunbiyi O; Ozturk M
Afr J Med Med Sci; 2001; 30(1-2):125-7. PubMed ID: 14510167
[TBL] [Abstract][Full Text] [Related]
16. Iron overload and hematologic malignancies.
Franchini M; Veneri D
Hematol J; 2004; 5(5):381-3. PubMed ID: 15448663
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
Wang XH; Wang PL
Ai Zheng; 2003 Jul; 22(7):715-8. PubMed ID: 12866962
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Lehman TA; Greenblatt M; Bennett WP; Harris CC
Drug Metab Rev; 1994; 26(1-2):221-35. PubMed ID: 8082567
[No Abstract] [Full Text] [Related]
19. [Premalignant lesions and hepatocellular carcinoma on non cirrhotic liver overloaded with iron].
Attia A; Blanc JF; Saric J; Balabaud C; Bioulac-Sage P
Gastroenterol Clin Biol; 2000 Oct; 24(10):955-9. PubMed ID: 11084432
[TBL] [Abstract][Full Text] [Related]
20. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
